ALBO

Albireo Pharma, Inc. Common Stock
ALBO

Overview Fund Activity
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

30 hedge funds and large institutions have $81.8M invested in Albireo Pharma, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
30
Holders Change
+8
Holders Change %
+36.36%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
9
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PA
1
Perceptive Advisors
New York
$33.8M
2
AG
2
Artal Group
Luxembourg
$7.68M
3
SAM
3
Sectoral Asset Management
Quebec, Canada
$6.22M
4
Millennium Management
4
Millennium Management
New York
$1.19M
5
AAP
5
Ardsley Advisory Partners
Connecticut
$289K

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$0
2
SFM
2
Sphera Funds Management
Israel
$907K
3
Deutsche Bank
3
Deutsche Bank
Germany
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$3.09M
5
JMH
5
J.M. Hartwell
New York
$241K
Name Market Value Shares Shares
Change 		Shares
Change %
PMFA
26
Plante Moran Financial Advisors
Michigan
$1K 49 – –
LTFS
27
Ladenburg Thalmann Financial Services
Florida
$1K 33 – –
Point72 Asset Management
28
Point72 Asset Management
Connecticut
– – -186,640 Closed
Deutsche Bank
29
Deutsche Bank
Germany
– – -68,060 Closed
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
– – -200 Closed
Bank of America
31
Bank of America
North Carolina
$0 4 -44 -92%
Group One Trading
32
Group One Trading
Illinois
$0 2 – –
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$0 10 +10 New
1
2